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Dynamic and reciprocal interactions generated by the communication between tumor cells and their 
matrix microenvironment, play a major role in the progression of a tumor. Indeed, the adhesion of 
specific sites to matrix components, associated with the repeated and coordinated formation of 
membrane protrusions, allow tumor cells to move along a determined pathway. our study analyzed 
the mechanism of action of low-diluted Phenacetinum on murine cutaneous melanoma process in a 
fibronectin matrix environment. We demonstrated a reduction of dispersed cell migration, early and 
for as long as 24 h, by altering the formation of cell protrusions. Moreover, low-diluted Phenacetinum 
decreased cell stiffness highly on peripheral areas, due to a disruption of actin filaments located 
just under the plasma membrane. Finally, it modified the structure of the plasma membrane by 
accumulating large ordered lipid domains and disrupted B16 cell migration by a likely shift in the 
balance between ordered and disordered lipid phases. Whereas the correlation between the excess of 
lipid raft and cytoskeleton disrupting is not as yet established, it is clear that low-diluted Phenacetinum 
acts on the actin cytoskeleton organization, as confirmed by a decrease of cell stiffness affecting 
ultimately the establishment of an effective migration process.
Directional motility is a physiological cellular process which is essential for embryogenesis, immune response, 
tissue repair, and organ formation. Cell types and environment influence the mode of migration, which can 
be individual (amoeboid or mesenchymal modes) or collective (cluster or sheet modes). Briefly, cell motility is 
characterized by a succession of steps including initiation of cell polarity, formation of protrusions at the leading 
edge, establishment of new adhesion sites, and rear tail retraction. This cycle dependent on multiple intracellu-
lar regulatory mechanisms involving connections with plasma cell membrane, can be controlled by extracellu-
lar matrix properties1,2. However, aberrant migration can also promote diseases such as cancer and metastatic 
spread. Indeed, during cancer progression, the migration of uncontrolled and isolated cells can cover local dis-
tances, disseminate in blood circulation, and develop metastasis in secondary organs3,4. Among all cancers, the 
rate of cutaneous melanoma has increased continually as 132,000 people are affected each year (World Health 
Organization). Moreover, the number of death cases has increased significantly for forty years (INCA, Institut 
National du Cancer, Oct 2013) especially when persistent in skin, lungs, lymph nodes, intestinal organs and brain. 
So, while primary cutaneous melanoma are mostly treated with a curative wide local excision5, in the case of a 
metastatic dissemination diagnosis, other therapeutic strategies have to be initiated. Among them chemotherapy 
(vemurafenib or dacarbazine), immunotherapy which represents a promising way of treatment targeting immune 
check points (PD1, Programmed Cell Death; CTLA, Cytotoxic T-Lymphocyte-Associated Protein), targeted ther-
apy using inhibitors of B-RAF or cell therapy meant to boost T lymphocytes activity and radiotherapy (localized 
ionizing radiation), are used alone or in combination so as to increase their efficacy6. However these treatments 
are generally considered ineffective for metastatic melanoma leading frequently to the development of chronic 
side effects, toxicity in patients and sometimes to therapeutic failures5,6. Therefore, the use of complementary 
and alternative medicines (CAM) as integrative therapy by cancer patients, in parallel with anticancer treatments 
prescribed by oncologists, has increased considerably over the past 30 years7. Homeopathy is part of these CAM. 
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Developed in the 18th century by German physician Samuel Hahnemann, it is based on two principles: the Law 
of Similars (“similia similibus curantur; let likes be cured by likes”) and Individualisation, and it makes use of a 
specific form of remedy preparation, the stepwise dilution and potentisation8–10. The effect of homeopathy has 
already been recognized, especially for improving the cancer patients’ quality of life11,12, and many studies have 
only begun to demonstrate the effect of some homeopathic dilution in cancer cell lines, in vitro. For instance, 
Lycopodium clavatum 5 Centesimal Hahnemannienne (CH) and 15CH have the capacities to induce apopto-
sis in HeLa cancer cells13, and the “Canova method” composed of several homeopathic dilutions, can stimu-
late the immune system by activating macrophages14. Furthermore, a recent study shows that Ruta graveolens 
30CH is able to decrease cell viability and cell migration, by increasing apoptosis of the human colon cancer15. 
Considering all these facts and despite a context that tends to question the existence of any effect related to home-
opathic treatments, we have decided to evaluate the impact of low homeopathic dilutions of phenacetine in vitro 
on melanoma cell lines. The chemical basis of this homeopathic dilution is phenacetine, an aromatic organic 
compound known as a drug with analgesic and anti-pyretic properties, comparable to paracetamol and produced 
in the United States in the 1920s (IARC 1977, FDA 1999). Until 1983, phenacetine was used over-the-counter 
in remedies for pain and fever and also in rheumatoid arthritis, but the established presence of carcinogenicity 
in renal pelvis and urinary bladder caused its withdrawal from the market16. However, despite these harmful 
effects, some studies have demonstrated that the use of a substance potentially toxic yet highly diluted (such as 
cadmium and arsenic), can produce an effective reduction of their usual toxic aspect in vitro/in vivo and increase 
beneficial application17–19. Based on this knowledge, the present study will describe for the first time the effects 
of low-diluted Phenacetinum (Phenacetinum 4CH – 1 × 10−8 M), on cancer cell migration in vitro for murine 
cutaneous melanoma cell lines. Indeed, the combination of different original methodologies makes it possible 
for Phenacetinum 4CH to disrupt lipid organization at the plasma membrane, affecting underlying cytoskeleton 
performance and thereby, dispersed cell migration.
Results
Phenacetinum 4CH decreases 2-dimensional (2D) and 3-dimensional (3D) dispersed B16 cells 
distance and velocity migration. Figure 1 depicts the 24 h effect of Phenacetinum 4CH, on 2D dispersed 
B16 cells migration on fibronectin coating. Pictures in Fig. 1A, represent 60 trajectory profiles take randomly 
and blindly depending on the following conditions. The initial position of each cell was set at the origin (0,0) 
of coordinates, and the white circles in the center were determined to have about 2/3 control of the B16 cells 
outwards. In these conditions, representative tracks showed that among the 60% of cells outside the circle in 
control situation, only 43 to 45% were out when they were treated with Phenacetinum 4CH. Then, the diminution 
between the control cells and the treated cells outside circles was at 28 and 27.5% for B16F1 and B16F10 cells 
respectively. Supplementary information on Fig. 1B, obtained by tracking the total migratory paths on 24 h of 
random cells, allowed us to determine that B16F1 control cells migrated on average at 694 ± 11 μm for 24 h and 
B16F10 cells at 972 ± 18 μm. Under Phenacetinum 4CH treatment, the migratory capacities of B16 cells were sig-
nificantly reduced by 27% at 510 ± 9 μm for B16F1 cells, and by 31% at 670 ± 18 μm for B16F10 cells. Moreover, 
this diminution was apparent after 2 h, and sustainable up over 24 h (data not shown). In addition, analysis of 
the total migratory speed of random cells during 24 h, enabled to identify that B16F1 control cells migrated on 
average at 28.1 ± 0.4 μm/h and B16F10 cells at 40.5 ± 0,4 μm/h (Fig. 1C). Under Phenacetinum 4CH treatment, 
the migration capabilities were significantly reduced by 29% at 20 ± 0.8 μm/h for B16F1 cells, and by 31% at 
27.9 ± 0.8 μm/h for B16F10 cells (Fig. 1C). These results confirm that Phenacetinum 4CH decreased the distances 
of the cell migration by a decrease of the B16 cell migration speeds in a fibronectin context. Furthermore, we con-
firmed that the effect of Phenacetinum 4CH specifically acts on cell migration mechanism since we did not find 
any significant alteration in the cellular viability after 24 h of treatment compared to control cells (Supplementary 
Fig. S1). In a complementary way, we tested the effect of Phenacetinum 4CH on murine normal cells (Murine 
Embryonic Fibroblasts) to determine its specific action on cancer cell line. Indeed, there is no difference of migra-
tion distances during 24 h between control MEFs cells (215 ± 10 μm) and cells treated with Phenacetinum 4CH 
(217 ± 9 μm) (Supplementary Fig. S2A). In the same way, the migration velocity was not changed between control 
MEFs cells (21.5 ± 1 μm/h) and treated MEFs cells (21.7 ± 0.9 μm/h) (Supplementary Fig. S2B). Finally, we con-
firmed the effect of Phenacetinum 4CH in 3D migration using Boyden chamber, coated with fibronectin (Fig. 2). 
Indeed, our homeopathic dilution reduced significantly B16 cells migration after 6 h treatment of 29% for B16F1 
cells and 18% for B16F10 cells, as shown on the pictures and histograms quantification (Fig. 2A,B). These results 
allow us to grant Phenacetinum 4CH an inhibitory role on dispersed B16 cells migration in a fibronectin context.
Phenacetinum 4CH decreases B16 cell polarity and living cells stiffness. Efficacy of cell migration 
is caused by a succession of membrane protrusions allowing the development of cell polarity. To investigate mor-
phological changes of cells induced by Phenacetinum 4CH, their circularities have been studied. The histogram 
presented in Fig. 3A demonstrates, than on average over 24 h, that control B16 cells showed a balance between 
circular (1) and polarized (0) phenotype with values at 0.45 ± 0.002 for B16F1 cells and 0.51 ± 0.002 for B16F10 
cells. In control, these cells spread and advanced along a determined and polarized trajectory from pathways over 
24 h, due to flat protrusions at the leading edge apparent at 0 h, 12 h and 24 h (white arrows on blue and green 
pathways, Fig. 3B). On the contrary, treated cells exhibited a more circular phenotype (Fig. 3A), of 26% for B16F1 
cells with values of cell circularity at 0.57 ± 0.002 and 25% for B16F10 cells with values at 0.64 ± 0.002. Indeed, 
treated cells revealed reduced and randomized trajectories observable after 12 h with B16F1 cells, and mainly 24 h 
with two cell types (red pathways, Fig. 3B). The impact of Phenacetinum 4CH on migration distance and forma-
tion of cell protrusions prompted us to study the mechanical properties of cells. Determination of cell stiffness 
was conducted with Atomic Force Microscopy (AFM) by Peak Force Quantitative Nanomechanical Mapping 
measurements (PFQNM mode). Indeed, AFM nanomechanical measurements combine imaging and indentation 
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spectroscopy to map the spatial distribution of cell mechanical properties, which in turn reflects the structure and 
function of the underlying cytoskeleton20. Analyzes were made on perinuclear areas, to get rid of the nucleus and 
membrane extensions which will lead to artefacts in the mechanical measurements. For the different conditions, 
Fig. 3C shows the topography of the cells in 3D while the color code is linked to the values of the reduced Young’s 
modulus (elasticity modulus). After 1 h, B16 treated cells showed an important decrease of Young modulus (char-
acterized by blue color instead of the pink one for the non-treated cells, Fig. 3C). Phenacetinum 4CH caused a 
decrease of cell stiffness by factor 9.5 (3.8 ± 1.9 kPa to 0.4 ± 0.2 kPa) for B16F1 cells, and by factor 5.8 (5.9 ± 3.7 
kPa to 1.0 ± 0.6 kPa) for B16F10 cells (Fig. 3D). In addition, Phenacetinum 4CH did not alter MEFs cell stiffness 
(Young modulus value at 8.4 kPa ± 0.8 for control fibroblasts and 7.7 kPa ± 0.9 for treated fibroblasts) which 
implies that it has no effect on the actin cytoskeleton integrity (Supplementary Fig. S3A,B). As a conclusion, these 
results indicate that Phenacetinum 4CH is able to specifically decrease B16 cell stiffness, disturbs the cell polarity, 
and quickly influences the persistence of the trajectories followed by cells.
Phenacetinum 4CH disrupts actin filaments of living B16 cells. To confirm results obtained on cell 
stiffness, we assessed the effect of Phenacetinum 4CH on actin cytoskeleton by immunofluorescence assay (Fig. 4). 
After 1 h, control cells were polarized with longer aligned and parallel stress fibers (white arrows, Fig. 4A,F). 
Treated cells showed a few stress fibers (white arrows, Fig. 4B) with cortical actin beginning to disrupt (white 
dotted circles, Fig. 4B,G) and sometimes lose their sense of polarity (dotted blue arrow, Fig. 4G). After 6 h of 
Figure 1. Effect of Phenacetinum 4CH on dispersed B16 cells distance and velocity 2D migration. For 2D 
dispersed migration, B16 cells were seeded on fibronectin [1.2 μg/cm2] and tracked for 24 h using Manual 
Tracking plugin. (A) Data obtained were analyzed by chemotaxis plugin (trajectories of 60 cells per image) on 
ImageJ software, and quantification of average distance traveled in 24 h was expressed in μm, n = 8 for B16F1 
and n = 3 for B161F0, ***p < 0,001 (B).
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treatment, control cells were still polarized with a leading edge, retraction tail and stress fibers (white arrows, 
Fig. 4C,H). Moreover, in contact with Phenacetinum 4CH for 6 h, cells adopted a more circular phenotype along 
with an important disruption of cortical actin (orange dotted circle, Fig. 4D,I). Finally, the control cells exhibited 
mainly an actin cytoskeleton network with stress fibers highly organized (white arrows) and on the contrary, 
treated cells with Phenacetinum 4CH induced an important disintegration of actin cytoskeleton network. After 
1 h or 6 h, 80% of control B16F1 cells showed a stress fiber network (Fig. 4E). B16F10 control cells exhibit 67% 
of stress fibers cytoskeleton (Fig. 4J). So, in a general way, the majority of the B16 control cells population main-
tain an organized actin network over time. Ultimately and consistently with previous images, after 1 h or 6 h of 
treatment with Phenacetinum 4CH the quantity of cells positives for cell fibers was decreased of 30% for B16F1 
cells (Fig. 4E) and of 25% for B16F10 cells (Fig. 4J). These results demonstrate that Phenacetinum 4CH causes an 
increase of the actin network destruction and disorganization of B16 cells on fibronectin, while this being known 
to play a crucial role in cell migration.
Phenacetin molecules interact with membrane by way of molecular dynamic (MD) simula-
tion. Our data suggest that phenacetin action could be the result of an interaction with plasma membranes. 
In order to explore the localization of phenacetin at the membrane, we developed an original approach using 
molecular dynamic simulations. MD simulations of 500 ns were performed on several lipid bilayers 1-palmitoyl-2
-oleoylphosphatidylcholine (POPC), 1,2-dipalmitoylphosphatidylcholine (DPPC), and DPPC:cholesterol, of an 
increasing degree of order, and with a phenacetin/lipid ratio of 1/10. At the beginning of the simulation, phen-
acetin molecules were positioned outside the bilayer at around 1 nm of the membrane surface. As the simula-
tion ran on, phenacetin molecules rapidly insert into close interaction with the bilayer as seen in both panels of 
Fig. 5A, which highlights the penetration of the phenacetin inside the hydrophobic core (the center of the mass 
of phenacetins was in average at 1.2 nm from the POPC membrane). Phenacetin behaved similarly with the three 
lipid membrane compositions. Figure 5B also shows that this molecule is able to cross the lipid bilayer (orange 
curve presented by black arrow) and get out of the membrane into the bulk. A more thorough examination of 
the position of phenacetin molecules during the trajectory (Fig. 5A) revealed that phenacetin adopted a specific 
orientation in the membrane with its amide group near lipid polar heads and its more deeply inserted ether 
group. Phenacetin had an optimum angle of around 20° relative to the bilayer normal, which decreased with the 
membrane order (see Supplementary Fig. S4). Phenacetin formed hydrogen bonds with lipid head groups, mainly 
glycerol, and was also able to form hydrogen bonds with itself (Table 1). Phenacetin can indeed form small clus-
ters as shown in Supplementary Fig. S5 and a RDF between 2 and 3 as well.
Phenacetinum 4CH increases lipid ordered domains of living B16 cells. In order to investigate 
the benefits gained from the Phenacetinum 4CH mechanistic effect on B16 cells and on basis previous MD 
Figure 2. Effect of Phenacetinum 4CH on dispersed B16 cells 3D migration. For 3D cell migration, B16 cells 
were seeded on Boyden chamber coated with fibronectin [1.2 μg/cm2] and allowed to migrate for 6 h. Percentage 
of nuclei (under the polycarbonate membrane) was counted by ImageJ software, n = 4, (scale are, 50 μm). (C) 
Data are expressed as means ± SEM.
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information, we studied its action on the phospholipid organization contained in the plasma membrane of cells 
plated on fibronectin. The data presented on Fig. 6 show a different distribution of fluorescence depending on 
conditions after 1 h of treatment. Results indicated (Fig. 6A) homogeneity between disordered lipid phases (Ld, 
Figure 3. Influence of Phenacetinum 4CH on cell circularity and cell stiffness of living individual B16 cells. 
The average cell circularity (from 0 to 1 in the sense of circularity) of these cells was studied on same cells 
with ImageJ, n = 4 for B16F1 and B16F10 cells, ***p < 0,001 (A) and the typical profile of trajectories of these 
cells (scale bar, 50 μm), treated or not during 24 h, is illustrated in (B). After 1 h of treatment, cell stiffness of 
dispersed living B16 cells, seeded on fibronectin [1.2 μg/cm2], were studied and their elastic properties (Pa). 
Topographic images are represented in 3D while the color code is linked to the cell Young’s modulus values (log 
Pa unit) according to the experimental condition. Both are representative of the cell behavior for each condition. 
(C) The average values of Young’s Modulus on perinuclear areas are represented in box and whiskers, n = 6 for 
B16F1 and B16F10 cells, ***p < 0,001. (D) Data are expressed as means ± SEM.
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in blue fluorescence) and ordered lipid phases (Lo, in red fluorescence) in B16F1 control cells, unlike B16F10 cells 
(Fig. 6C) showing a majority of Ld phases. When cells were treated with Phenacetinum 4CH, we observed large 
and localized Lo domains (white arrows, Fig. 6B,D). In order to measure and quantify plasma membrane order, 
the histogram presented in Fig. 6E, indicates generalized polarization (GP) values of perinuclear areas. In control, 
we noticed that B16F1 had an average GP value of −0.04 ± 0.03 and B16F10 an average GP value of −0.47 ± 0.02. 
Homeopathic drug treatment causes an increase of GP values of 0.01 ± 0.03 and −0.37 ± 0.02 for B16F1 and 
B16F10 respectively. To conclude, Phenacetinum 4CH induces a 27% shift in B16F10 cells and 18% in B16F1 cells 
to increase their membrane stiffness on fibronectin and after 1 h of treatment (Fig. 6F).
Discussion
In general, results of in vitro studies, animal studies and clinical trials suggest that combine homeopathy with con-
ventional cancer care might have some beneficial effects against tumor progression and mainly on the life quality 
of patients suffering from cancer11,12,21. Interestingly, it has been observed that global health status, fatigue symp-
toms and other side effects did improve during cancer treatments accompanied with homeopathy21. Concerning 
cutaneous melanoma, it is well established that primary tumors are mostly treated by means of a curative local 
excision, but the survival rate of patients is largely reduced when metastases are diagnosed6. Evidence of efficacy 
being disputed, more study and particular preclinical study on homeopathy associated with allopathic treatments 
Figure 4. Behavior of Phenacetinum 4CH on actin cytoskeleton organization of living individual B16 cells. 
B16 cells were seeded on fibronectin [1.2 μg/cm2] and treated for 1 h and 6 h with Phenacetinum 4CH. Cells 
were fixed with glutaraldehyde, permeabilized with TritonX-100, and stained with Phalloïdin-Alexa Fluor 488 
(actin filament in green). Samples were visualized using epifluorescence microscope, objective 20× (scale bar, 
10 μm). The white arrows show actin stress fibers (A–C,F and H), dotted blue arrow shows a loss of polarity 
(G), dotted white and orange circles show a disruption of cortical actin (B,D,G and I). Profile types like stress 
fibers (organized actin networks) was quantified for B16F1 (E) and B16F10 cells (J) in each condition and 
representative of presented data. They are expressed in percentage, n = 4 where 60 cells were analyzed per 
condition and experiment, (ANOVA *p < 0.05 **p < 0.01).
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are needed aiming to reduce adverse effect. Indeed, several in vivo and in vitro preclinical studies have investigated 
the effect of homeopathy in different cancers. More particularly in the case of metastatic melanoma cancer, Sunila 
et al. highlighted a significant inhibition of lung metastasis with B16F10 cells by Thuja occidentalis, a homeopathic 
alcoholic extract induced in murine model22. This was confirmed by others using a composed homeopathic mix-
ture, called M1 product23. Regarding in vitro axis, Ghosh et al. demonstrated that the homeopathic mother tinc-
ture of Phytolacca decandra induces apoptosis of A375 melanoma cells by activating caspases-mediated signaling 
and ROS generation24. On the other hand, no effect was observed on melanoma cells with Zincum metallicum25. 
Although these previous studies are encouraging, the particular action of the mechanism remains unclear.
In this study, we defined the specific conditions associated with a dispersed cell culture model to investi-
gate in vitro for the first time the role of the homeopathic Phenacetinum 4CH dilution, on murine melanoma 
cell lines. To mimic the physio-pathological conditions connected with cutaneous melanoma progression, 
we analyzed the behavior of B16 cells grown on fibronectin matrix26–29. To better address the action mecha-
nisms of Phenacetinum 4CH, its effect on murine normal cells as a negative control was tested. Interestingly the 
lack of effect of Phenacetinum 4CH on key parameters of MEFs cells, such as cell migration and cell stiffness, 
strongly confirms its specific action on cancer cells. Our data showed that under Phenacetinum 4CH treatment, 
the development of membrane protrusions was anarchic, which reduced quickly and sustainably the dispersed 
cell migration. Moreover, we demonstrated that this treatment induced disruption of actin filaments underlying 
plasma membrane. Finally, we considered that reinforced by MD simulations, Phenacetinum 4CH upset the lipid 
membrane organization in increasing Lo domains. Hence, by disturbing the membrane fluidity associated to the 
disruption of cytoskeleton architecture and its dynamic, Phenacetinum 4CH altered the progression of murine 
melanoma cells as observed in the 2D and 3D migration experiments.
Firstly, we report that only after 1 h of treatment, the application of Phenacetinum 4CH on B16 cells reversed 
the lipid balance of plasma membrane, increasing the level of Lo phases. Plasma membrane contained a multi-
tude of lipids and proteins, which are specific to characteristic domains known as lipid rafts. These lipid domains 
essential for cell signaling, are enriched in saturated lipids (mainly sphingolipids) and in sterols (mainly choles-
terol) assimilated in most cases to Lo phases30,31. They are characterized by an important rigidity with a higher 
density of packing, as opposed to Ld phases composed of unsaturated lipids and defined as fluid30–32. Based on 
Figure 5. Molecular dynamics simulations of 25 phenacetins in presence of a POPC bilayer, and hydrogen 
bonds formed by phenacetins. Representative snapshot of the system with phosphorus (tin color) and 
phenacetins depicted using the van der Waals representation and the lipids with a line representation. (A) The 
phenacetin structure is presented in the inlet panel. Z coordinates of the phenacetin’s center of mass. (B) Black 




COC – CONa 0.12 0.06 0.08
CON – CON 3.39 2.96 4.97
CON – Phosphate 8.66 7.64 5.61
CON – Glycerol 21.37 23.77 23.30
COC – Cholesterol 0.45
CON – Cholesterol 1.00
CON – water 127.88b 112.94b 106.20b
COC – water 14.94 9.73 6.19
Table 1. Phenacetins interactions. Values correspond to the percentage of the simulation time during which 
hydrogen bonds are observed per phenacetin. aCOC and CON correspond respectively to the ether and amid 
group of the phenacetin. bValues greater than 100 means that several hydrogen bonds are formed at the same 
time.
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this knowledge, we suggest that Phenacetinum 4CH may increase the rigidity of the plasma membrane, involving 
probably an elevation of cholesterol level. In this sense, preliminary results seem to demonstrate an increase of 
membrane cholesterol level, when B16 cells are treated with Phenacetinum 4CH (data not shown). However, as 
described earlier, we know that membrane fluidity of cancer cells was directly and significantly correlated with 
the malignant potential of these cells33–35. For example, Hendrich et al., hypothesized that low concentration of 
cholesterol in plasma membrane allowed cell membranes to be more easily deformable, making them highly 
metastatic36. Conversely, we can suppose that Phenacetinum 4CH treatment decreases the metastatic power of 
Figure 6. Effect of Phenacetinum 4CH on structural membrane of living individual B16 cells. B16 cells were 
seeded on fibronectin [1.2 μg/cm2], incubated with Laurdan (di-4-ANEPPDHQ) [5 μM] overnight at 37 °C 
and then treated with homeopathic drug. After 1 h, living cells were excited at 800 nm with bi-photon confocal 
microscope, immersion objective 60× (scale bar, 10 μm). Then, camera capture two simultaneous images with 
wavelengths range to 400–460 nm (liquid-ordered phase ≪lo≫, in red) and 470–530 nm (liquid-disordered 
phase ≪ld≫, in blue). White arrows show ordered lipid phases. (A–D) Emission intensity of pixels was 
introduced in generalized polarization equation which provides GP values as a measurements of membrane 
fluidity. Quantification of GP values are ranged from −1 (more fluid) to +1 (more rigid), n = 4 for B16F1 and 
B16F10 cells, *p < 0.05 (E and F). Data are expressed as means ± SEM.
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melanoma cells, through an increase of membrane rigidity. Moreover, MD simulations allowed us to understand 
better atomic interactions with model membranes, as shown recently by Fei et al. highlighting new molecular 
mechanism of resveratrol37. Thus, resveratrol seems to show effects opposed to cholesterol in DPPC liquid phase 
as it decreases membrane thickness imposed by its orientation37. In our view, MD simulations showed that phen-
acetin molecules, contained in the low homeopathic dilution assessed here, were able to get spontaneously into 
POPC and DPPC lipid bilayers. They could position themselves perpendicularly on the bilayer surface and form 
clusters occasionally. In addition, their specific orientation in the membranes allowed them to establish hydrogen 
bridges between glycerol groups of phenacetin molecules and hydroxyl groups of cholesterol. Also, thanks to the 
greatly reduced complexity of the lipid membrane structure construction, these MD simulations data allowed us 
to consolidate the previous results indicating that Phenacetinum 4CH could get into biological membranes and 
increase the membrane rigidity through the accumulation of Lo phases. Similarly, already reported was the fact 
that some flavonoids molecules like Genistein could alter membrane fluidity by accumulation in lipid rafts and 
induce cell apoptosis through recruitment of Fas/CD95 at the plasma membrane32,38,39. It therefore seems that a 
rise of lipid rafts may influence the cellular homeostasis. Indeed, it is widely accepted that lipid rafts are involved 
in many cellular processes such as signal transduction, cholesterol transport, membrane trafficking, cytoskeletal 
organization, motility, polarity and endocytosis40. Chun et al. attested in Hela cells that an increase of membrane 
cholesterol levels decreased phosphatidylinositol 4,5-biphosphate (PIP2) via an important activation of phos-
pholipase C (PLC)41. Cholesterol- and sphingolipid-rich rafts are then able to confine PIP2 within the plasma 
membrane leads to limit its activity. However, this phospholipid is an important regulator in a variety of cellular 
functions, since it can be involved in calcium and PI3K/AKT signaling pathways. Moreover, its presence in the 
plasma membrane may allow the recruitment and activation of effectors, such as guanine nucleotide exchange 
factors (GEFs) or GTPases accelerating protein (GAPs) to small Rho-GTPases involved in remodeling of actin 
cytoskeleton and cell motility42.
Ultimately, composition and structure of the plasma membrane and the underlying motility machinery 
seem to be tightly connected through a successful coordination of many cellular processes. Using the highly 
sensitive and spatial resolution of AFM approach, our results on cell mechanical properties reveal that after 1 h, 
Phenacetinum 4CH induces a strong reduction of B16 cell stiffness. As demonstrated in many publications, the 
actin cytoskeleton integrity brings a significant contribution to an optimal cell stiffness. Indeed, the depolym-
erization of actin filaments by different chemicals treatments like Cytochalasin D or Latrunculin B, was accom-
panied by a reduction of cell stiffness20,43,44. In our study, the application of an indentation force around 70 nm 
enabled to confirm that we directly analyzed cortical actin (generally between 50 and 200 nm of depth depending 
of the cells)45. In that way, the rapid increase of cell fluidity induced by Phenacetinum 4CH directly reflects a 
perturbation of the structure and/or function of the underlying actin cytoskeleton that may result in a reduction 
of membrane-cytoskeleton adhesion. This assumption was supported by immunofluorescence assays, since we 
observed a considerable disruption of actin filaments network under Phenacetinum 4CH treatment. Thus, the 
membrane-cytoskeleton system governs cellular elastic properties, essential for cell migration45.
Cells contain two types of actin filaments. Stress fibers are parallel to the direction of movement and bind 
themselves to myosin II to provide contraction force. Conversely, cortical actin branched network is polymer-
ized under the plasma membrane which promotes cell deformation by protrusion formation45,46. Among these 
membrane protrusions, the lamellipodia generate protrusive activity at the leading edge, involving polarity and 
cell motility. On the contrary, our present results demonstrated that Phenacetinum 4CH was able to impede 
the polarity of B16 cells by the development of many peripheral lamellae, which increase the cell circularity. 
Indeed, involvement of many proteins to generate a lamellipodia by nucleation of actin filament must be coor-
dinated to induce directional cell motility47. On the one hand, WAVE protein may be an essential regulator of 
lamellipodia formation with Arp2/3 complex, to initiate new filaments as a branch on the side of an existing fila-
ment48–50. On the other hand and more generally, extension of a single lamellipodium can be regulated by several 
other proteins47,51. Among them, the small Rho-GTPases were recognized as controlling the formation of actin 
cytoskeleton and cell morphology; Rac generates protrusive forces through actin polymerization in F-actin at the 
leading edge, Cdc42 proteins have a crucial role at the front of cells to control direction of migration and Rho 
is responsible to rear tail retraction by stress fibers formation52,53. Taken together, these molecular mechanisms 
generate a front-rear axis essential for unilateral cell polarity51,53–55. Indeed, Dua et al., confirmed the importance 
of RhoA and Rac1 using a Pentoxifylline molecule which was able to avoid migration of B16F10 cells, affecting 
expression of these small molecule reducing stress fibers and lamellipodial protrusions56. Similarly, another study 
also demonstrated the importance of cholesterol in membrane-cytoskeletal dynamic, since cholesterol deple-
tion results in Src kinase-mediated Rho activation and stress fibers formation57. Hence, being correlated to these 
releases our data suggested a malfunction of Rho-GTPases signaling pathways. Moreover, as actin cytoskeleton in 
connection with the plasma membrane provided the structure and the shape of cells, the cellular disorientation 
and disruption of actin network observed under Phenacetinum 4CH treatment could be closely related.
Finally, the cascade of these multiple events under homeopathic drug treatment, leads to decrease the B16 cells 
velocity leading to a reduction of the distance traveled by B16 dispersed cells, after 2 h and in a sustainable way up 
to 24 h. However, during tumor progression, it is the development of aberrant and individual cell migration which 
promotes metastatic dissemination to a site or organ distant from a primary tumor1,58. In fact, many reports have 
described that effective mesenchymal cell migration was composed through a cyclic persistent process of different 
steps: protrusion, adhesion, contraction and retraction of cells towards a specific direction2,3,59. In conclusion, our 
results propose that Phenacetinum 4CH influences protrusion and retraction processes, limiting the capacity of 
single cell to cover local distance.
Taken together, our data allowed us to highlight an in vitro action mechanism of Phenacetinum 4CH home-
opathic dilution, as a specific disruptor of murine melanoma cell migration on a fibronectin matrix. Indeed, 
the likely insertion of Phenacetinum 4CH into the plasma membrane of B16 cells, strongly comforted by MD 
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simulations, appears to disturb their organization as evidenced by an increase of Lo phases. Also, we suggest 
that these molecular phenomena will impair signaling pathways from lipid rafts and cholesterol contained in the 
plasma membrane, involve probably different second messengers (such as PIP2, Rho-GTPases or Ca2+) which 
may affect the actin network and result in the loss of directional cell migration. The impact of Phenacetinum 4CH 
on the signaling platforms and the disturbing underlying cascades remains to be studied. However, this pioneer-
ing work properly addresses the effect of homeopathy on tumor progression cells lines, as a way of associating it 
to conventional subsequent treatments.
Methods
Cells lines and reagents/antibodies. B16F1, B16F10 (murine melanoma cell lines), NIH3T3 (murine 
embryo fibroblast cell line) and MEF (murine embryonic fibroblast) were purchased from ATCC. The cells 
were cultured in RPMI 1640 supplemented with 10% fetal bovine serum (FBS) in standard conditions (5% CO2, 
37 °C). Both cell lines were used at low passage number (<15) and were mycoplasma free (MycoAlert; Lonza). 
Fibronectin, Mitomycin C and Laurdan were obtained from Sigma Aldrich (France). RPMI 1640 medium was 
obtained from Gibco (France). Fetal Bovine Serum (FBS) was obtained from ATCC. The probe used in this study 
is an anti-phalloïdin coupled to Alexa-fluor 488 (Invitrogen). Homeopathic dilution, Phenacetinum 4CH, was 
obtained from BOIRON laboratories (Messimy, France): 1 g of Phenacetine was firstly diluted in 99 ml d′H2O. 
This dilution was repeated four times (1 × 10−8) to obtain a final concentration at 0.563 nM.
Cell viability assay. The cells were seeded at a density of 5 × 103 cells/well in a 96-well culture plate. 
Homeopathic drugs are administrated in wells for 5% and stopped after 0 h or 24 h of incubation (5% CO2, 37 °C). 
For that, 20 μL of MTT solution at [5 mg/ml] were added in wells and incubated during 3 h (5% CO2, 37 °C). The 
media were gently removed and 100 μL of DMSO were added to dissolve formazan crystals. MTT reduction was 
quantified by measuring the light absorbance at 570 nm using the reader microplate (TECAN, Infinite). Each 
experiment was repeated three times.
Migration into dispersed cells assay. The B16 cells were seeded at a density of 7.5 × 103 cells/well and the 
MEF cells at 3.5 × 103 cells/well in a 24-well culture plate. To put it briefly, cells were grown on a fibronectin-coated 
surface (7 μg/mL) for 24 h, then treated with mitomycin C (1 μg/mL) for 2 h. Then after, cells were rinsed twice 
with medium low serum and treated with 5% of homeopathic dilution in RPMI 1640 0.5% FBS. The plate was 
placed on the stage of a fully-motorized inverted microscope (AxioObserver Z1, Zeiss) equipped with an envi-
ronmental chamber (5% CO2, 37 °C). For each experiment, time-lapse images of several fields were acquired 
every 10 min over a 24 h period, using a 10x phase contrast objective (Numerical Aperture N.A. 0.3, 0.65 μm/
pixel, binning 1). Cell tracking was performed using Manual Tracking plugin of Fiji where 60 individual cells 
were tracked per treatment for each experiment during 24 h of the migration. The data obtained were used with 
Chemotaxis software tool for another representation of tracks. At least three experiments were conducted for 
each condition examined in the present study.
transwell migration assay. A 24-well Transwell chamber (Greiner Bio-One, Dutscher, France) with a 
8-μm pore PET membrane, was used to perform the migration assay and coated with fibronectin at 7 μg/mL. 
The lower chamber was filled with 600 μL RPMI 1640 conditioned medium (made with NIH3T3 cell line). Then, 
200 μL B16F1 or B16F10 melanoma cells suspension (2.5 × 105 cells/mL with 0.5% FBS), containing 5% of home-
opathic dilution, were added to the insert. The cells were allowed to migrate at 37 °C with 5% CO2 over 6 h. The 
inserts were washed in PBS and fixed with methanol for 15 min. Non-migrating cells were removed from the 
upper surface of the inserts by gently scrubbing with a cotton-tipped swab. Each PET membrane were cut and 
stained with mounting medium DAPI (ProLong Gold DAPI, ThermoFischer), between blades and slats. For 
counting, 10 pictures were taken per membrane, and each condition was made in duplicate. Experiments were 
performed at least in triplicate.
Cell circularity and cell polarity. Cell morphology was quantified using circularity index on ImageJ soft-
ware by the following formula: 4π(area)/(perimeter)2. This formula gives a circularity index ranging from 0 at 1, 
where value 0 corresponding to elongated shape and value 1 to a rounded morphology. Cells were chosen ran-
domly from tracking obtained previously by time-lapse movies, and the average of the contours was made on 0, 
6, 12, 18 and 24 h. Experiments were performed at least in triplicate.
Atomic force microscopy. The AFM utilized in this study is the Bioscope CatalystTM (Bruker, Billerica, 
USA) coupled to a Nikon Eclipse Ti inverted microscope (Nikon, Tokyo, Japan). The glass-bottom petri dishes 
(50 mm in diameter, WillCo Wells, Amsterdam, the Netherlands) were put onto the AFM stage and observed with 
Bright Field illumination in order to locate the cells. One day prior to the experiments, B16 cells were seeded at 
a density of 5 × 104 cells/mL and MEF cells at 2.5 × 104 cells/mL on the plates previously coated with fibronectin 
(7 μg/ml). After a 24 h period, the cells were rinsed twice with medium low serum and treated with 5% of homeo-
pathic dilution in RPMI 0.5% FBS, for 1 h at 37 °C, 5% CO2. All images were captured in Peak Force Quantitative 
Nanomechanical Mapping (PFQNM) mode. PFQNM-LC-A-CAL probes, having a nominal spring constant of 
0.1 N/m and a resonance frequency of ~45 kHz were used to image the cells, the tips being calibrated with the 
company protocol and as previously described where the Young’s moduli were calculated by using a Sneddon 
fit60. For PFQNM experiments, we used a PeakForce frequency of 0.25 kHz in order to maximize the contact time 
between the tip and the sample. The PeakForce amplitude was set at 1 μm. The loading force was lowered down 
to a few tens of pN to avoid generating mechanical stress of the cells. The indentation force applied on cells was 
between 50 and 100 nm, directly on cortical actin. Images were captured in culture medium at a resolution of 256 
or 128 pixels per line, at 37 °C using a Perfusing Stage Incubator. Regarding the Young’s modulus calculation, a 
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minimum of 3 analysis on 3 different cells (perinucleus areas were avoided) were performed and the experiments 
were triplicated for each sample type.
Immunofluorescence staining. B16F1 and B16F10 were plated at low density onto plastic LabTek (Nunc, 
Dutscher, France) previously coated with 7 μg/mL of fibronectin for 12 h at 4 °C and blocked with 1% BSA. Cells 
were incubated on the LabTek for 24 h at 37 °C in 5% CO2 to allow spreading. Subsequently, cells were treated with 
5% homeopathic dilution in medium low serum during 1 h and 6 h at 37 °C and 5% CO2. They were rinsed once 
gently with medium low serum at 37 °C and once with glutaraldehyde 0.1% in PBS. Cells were fixed with gluta-
raldehyde 0.5% for 10 min at room temperature (RT). After two rinses with PBS, cells were saturated with 10% 
BSA for 1 h at RT. Cells were incubated with Alexa FluorTM 488 Phalloidin probe for 1 h, in 2% BSA/TBS-Triton 
X100 (1:100 dilution). After incubation, LabTek were washed in 0.1% Triton/TBS and mounted onto slides using 
mounting medium DAPI. Observation of LabTek were taken at fluorescent microscope (BX51WI, Olympus) Ex/
Em = 493/517 nm.
Laurdan two-photon microscopy. Laurdan is an amphiphilic fluorescent probe able to penetrate a biolog-
ical membrane, and to detect changes in membrane phase properties through its emission spectral shift. B16F1 
and B16F10 were plated at low density onto a cell culture dish (35 mm diameter, FluoroDish WPI), previously 
coated with 7 μg/mL fibronectin for 12 h at 4 °C and blocked with 1% BSA. At the end of the day, cells were rinsed 
twice with medium low serum, then 1.9 ml of this medium with 2 μL of Laurdan (2-dimethylamino(6-lauroyl)
naphthalene) at [5 μM] were added overnight at 37 °C. In the following morning, 100 μL of drug was added 
directly into a well, and around 10 cells were imaged with confocal microscope (LSM 710 NLO ZEISS). Laurdan 
intensity images were recorded simultaneously with emission in the range of 400–460 nm and 470–530 nm. 
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Molecular dynamic simulations. Phenacetin was studied by means of MD simulations in the presence of 
different compositions of membranes as constituted of 256 POPC, of 256 DPPC and finally of DPPC:cholesterol 
(230:26). All simulations were performed using the CHARMM36 force field62 and the phenacetin topology was 
generated with the CHARMM general force fields (Program version 1.0.0, CGenFF version 3.0.1)63. Membrane 
systems were generated by using the CHARMM-GUI membrane builder64–67 and the box filled with TIP3P 
water64. Either one or 25 phenacetines were placed 1 nm away from the membrane surface. All the systems stud-
ied were equilibrated by using the step equilibration proposed by the CHARMM-GUI membrane builder; a min-
imization by steepest descent of 1,000 steps, two NVT and four NPT simulations with increasing length and 
time step and at the end decreasing restraints force constant on lipids phosphate positions and dihedral angles. 
Phenacetines were also kept under position restraints before production simulations were performed.
statistical analysis. All data were expressed as mean ± SEM of at least three independent experiments. 
Software GraphPad Prism 6.0 was used for statistical analysis. The significance of the differences in the samples 
was measured by One Way ANOVA with Dunnett t-test. Differences were considered significant at p < 0.05.
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